2-(7-Hydroxy-5-phenethyl-[1,2,4]triazolo[1,5-a]pyridine-8-carboxamido)acetic acid

Catalog No. :
ACUPNB572
CAS No. :
1262132-81-9
Molecular Formula :
C17H16N4O4
Molecular Weight :
340.34

IUPAC Name:(7-hydroxy-5-phenethyl-[1,2,4]triazolo[1,5-a]pyridine-8-carbonyl)glycine

2-(7-Hydroxy-5-phenethyl-[1,2,4]triazolo[1,5-a]pyridine-8-carboxamido)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg97%$124.00Login to see priceIn stockInquiry
50mg97%$232.00Login to see priceIn stockInquiry
100mg97%$395.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(7-Hydroxy-5-phenethyl-[1,2,4]triazolo[1,5-a]pyridine-8-carboxamido)acetic acid
IUPAC Name(7-hydroxy-5-phenethyl-[1,2,4]triazolo[1,5-a]pyridine-8-carbonyl)glycine
Molecular FormulaC17H16N4O4
Molecular Weight340.34
SMILESO=C(O)CNC(C1=C(O)C=C(CCC2=CC=CC=C2)N3C1=NC=N3)=O
InChI KeyNALAUGMPMIVAOW-UHFFFAOYSA-N
SynonymC17H16N4O4 | CS-0031647 | Glycine, N-((7-hydroxy-5-(2-phenylethyl)(1,2,4)triazolo(1,5-a)pyridin-8-yl)carbonyl)- | JSK7TUA223 | UNII-JSK7TUA223 | Enarodustat (JTZ-951) | JTZ 951 | HY-109057 | BJ162590 | DB14985 | EX-A4798 | MS-25187 | 2-(7-Hydroxy-5-phenet
CAS No.1262132-81-9
PubChem CID50899324

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACUPNB572 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUPNB572 route product structure diagram
    ACUPNB5721262132-81-9 In Stock
Inquiry

2. ACUPNB572 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUPNB572 route product structure diagram
    ACUPNB5721262132-81-9 In Stock
Inquiry

Comments (0)